News Agency
The Times

Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical

  • Written by PR Newswire
Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical

Highlights

  • Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of copper isotopes for the diagnosis and treatment of cancer.
  • The product, termed SAR-bisFAP, has shown strong tumour targeting, retention and pharmacokinetic data to date in pre-clinical...

Read more: Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion